Chronic fatigue syndrome: I. Epstein-Barr virus immune response and molecular epidemiology.
Jones, J F, Streib, J, Baker, S et al. · Journal of medical virology · 1991 · DOI
Quick Summary
This study looked at how the immune system responds to Epstein-Barr virus (EBV) in ME/CFS patients compared to healthy people who have been infected with EBV. Researchers found that immune cells from ME/CFS patients were much more likely to grow uncontrollably in the lab (30% vs 8%), and patients showed more signs of active viral infection in their blood. These findings suggest that some ME/CFS patients may have difficulty controlling EBV reactivation.
Why It Matters
This research provides early immunological evidence that ME/CFS may involve abnormal immune control of EBV reactivation, a leading hypothesis about disease mechanisms. Understanding whether EBV plays a triggering or perpetuating role in ME/CFS could eventually lead to targeted immune-based treatments. The study's findings have influenced decades of subsequent EBV research in ME/CFS populations.
Observed Findings
Spontaneous lymphocyte transformation occurred in 30% of ME/CFS patients versus 8% of healthy seropositive controls
Viral genome patterns contained frequent polymorphisms in BamHI B', K, H, and Y fragments in both groups
19 cell lines showed linear (lytic) viral DNA form, suggesting active viral replication
ME/CFS patients produced antibodies to EBV lytic proteins more frequently than healthy controls
Only one cell line was found with the EBNA-2B genotype across all samples
Inferred Conclusions
ME/CFS patients have impaired ability to control EBV lymphocyte outgrowth in vitro
Impaired in vitro EBV control correlates with serological evidence of active viral infection in vivo
Some ME/CFS patients may experience ongoing or reactivated EBV infection as part of their disease
EBV immune dysregulation may be a feature of ME/CFS pathophysiology
Remaining Questions
Does impaired EBV control cause ME/CFS symptoms, or does ME/CFS develop independently and then allow EBV reactivation?
What percentage of ME/CFS patients actually have active EBV infection versus immune dysregulation without active virus?
What This Study Does Not Prove
This study does not prove that EBV causes ME/CFS or that EBV reactivation is present in all ME/CFS patients. The findings show correlation between impaired immune control and active viral markers, but cannot establish causation. The small sample size and open study design limit generalizability, and the results do not explain why only some EBV-infected people develop ME/CFS.